Metoclopramide-induced tardive dyskinesia in an infant.
We describe a 1-year-old girl who developed orofaciolingual stereotypy at age 2 months after a 17-day treatment with metoclopramide for gastroesophageal reflux. The stereotypy, documented by sequential videos, persisted for at least 9 months after the drug was discontinued. This patient represents the first documented case of tardive dyskinesia in an infant. We also review previous reports of tardive dyskinesia in children.
Mejia
Nicte I
NI
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.
Jankovic
Joseph
J
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003710:Demography; D018492:Dopamine Antagonists; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D007223:Infant; D008297:Male; D008787:Metoclopramide / Q000009:adverse effects*; D013239:Stereotyped Behavior / Q000502:physiology
D018492:Dopamine Antagonists; D008787:Metoclopramide